logo
Share SHARE
FONT-SIZE Plus   Neg

Probability, Glu Mobile Sign Mobile Gambling Deal

Mobile gambling specialist Probability Plc (PBTY.L) on Monday said it has entered into a strategic relationship for mobile gambling with Glu Mobile Inc. (GLUU), a developer and publisher of freemium games for smartphone and tablet devices.

Probability said it will leverage successful, existing Glu original IP to create a suite of Glu-branded real-money mobile slot games. The slot games will be distributed to audiences in Probability's regulated markets, initially the UK and Italy.

The company added that Glu original IP-branded casino games will be offered as part of the Probability portfolio to its direct customers on brands.

Under the deal, Probability will provide a comprehensive operational role, accepting all gambling-related regulatory responsibilities.

Probability CEO Charles Cohen said, "We have a unique opportunity to work with Glu to fashion great slots games that will appeal to our customers as well as those of our B2B clients. We look forward to deepening our relationship with Glu as we seek to expand our regulatory reach to new markets worldwide."

Niccolo de Masi, Chief Executive Officer of Glu Mobile, added, "We anticipate that as additional markets around the world open up to real-money mobile gaming we will expand our investment in the subsector. We view real-money mobile gaming as an opportunity to extend the reach of our successful original IP to new demographics, as well as deepen engagement and rewards for our players."

In London, Probability shares are currently trading at 75.12 pence, down 0.88 pence or 1.16 percent.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT